Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.44 |
| ▸ | DHFR | P00374 | 4/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.35 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14895067 | 0.81 | DYRK1A (0.39) | HTTKMT2ADYRK1APABPC1IDO1 | |
| SCHEMBL10375776 | 0.80 | DHFR (0.42) | DHFRADORA2APIK3CGHRH4DCPS | |
| SCHEMBL1219738 | 0.77 | TLR8 (0.44) | DHFRADORA2AIDO1PIK3CG | |
| SCHEMBL20780662 | 0.77 | CCR1 (0.45) | DHFRADORA2A | |
| SCHEMBL20145315 | 0.77 | TLR8 (0.44) | DHFRADORA2APIK3CGDCPS | |
| SCHEMBL29157221 | 0.74 | HTT (0.47) | HTTKMT2ADYRK1AADORA2AIDO1 | |
| SCHEMBL24506585 | 0.73 | KDM4E (0.40) | DHFRADORA2AHRH4 | |
| SCHEMBL19520168 | 0.73 | KCNH2 (0.58) | DHFRHRH4 | |
| SCHEMBL14819956 | 0.73 | KDM4E (0.36) | DHFRADORA2APIK3CGHRH4 | |
| SCHEMBL19520169 | 0.73 | PARP1 (0.40) | DHFRADORA2APIK3CGHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020150114-A1 | HETEROCYCLIC NLRP3 MODULATORS, FOR USE IN THE TREATMENT OF CANCER | INNATE TUMOR IMMUNITY, INC. (US) | 2020-07-23 | — | — | WO | disclosed |